Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11160363rdf:typepubmed:Citationlld:pubmed
pubmed-article:11160363lifeskim:mentionsumls-concept:C0003765lld:lifeskim
pubmed-article:11160363lifeskim:mentionsumls-concept:C0085201lld:lifeskim
pubmed-article:11160363lifeskim:mentionsumls-concept:C1416804lld:lifeskim
pubmed-article:11160363lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:11160363lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11160363lifeskim:mentionsumls-concept:C1511545lld:lifeskim
pubmed-article:11160363pubmed:issue1lld:pubmed
pubmed-article:11160363pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11160363pubmed:abstractTextPrevious studies have suggested that the helical repeat formed by residues 143;-164 of apolipoprotein A-I (apoA-I) contributes to lecithin:cholesterol acyltransferase (LCAT) activation. To identify specific polar residues involved in this process, we examined residue conservation and topology of apoA-I from all known species. We observed that the hydrophobic/hydrophilic interface of helix 143;-164 contains a cluster of three strictly conserved arginine residues (R149, R153, and R160), and that these residues create the only significant positive electrostatic potential around apoA-I. To test the importance of R149, R153, and R160 in LCAT activation, we generated a series of mutant proteins. These had fluorescence emission, secondary structure, and lipid-binding properties comparable to those of wild-type apoA-I. Mutation of conserved residues R149, R153, and R160 drastically decreased LCAT activity on lipid-protein complexes, whereas control mutations (E146Q, D150N, D157N, R171Q, and A175R) did not decrease LCAT activity by more than 55%. The markedly decreased activities of mutants R149, R153, and R160 resulted from a decrease in the maximal reaction velocity V(max) because the apparent Michaelis-Menten constant K(m) values were similar for the mutant and wild-type apoA-I proteins. These data suggest that R149, R153, and R160 participate in apoA-I-mediated activation of LCAT, and support the "belt" model for discoidal rHDL. In this model, residues R149, R153, and R160 do not form salt bridges with the antiparallel apoA-I monomer, but instead are pointing toward the surface of the disc, enabling interactions with LCAT. - Roosbeek, S., B. Vanloo, N. Duverger, H. Caster, J. Breyne, I. De Beun, H. Patel, J. Vandekerckhove, C. Shoulders, M. Rosseneu, and F. Peelman. Three arginine residues in apolipoportein A-I are critical for activation of lecithin:cholesterol acyltransferase J. Lipid Res. 2001. 42: 31;-40.lld:pubmed
pubmed-article:11160363pubmed:languageenglld:pubmed
pubmed-article:11160363pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160363pubmed:citationSubsetIMlld:pubmed
pubmed-article:11160363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160363pubmed:statusMEDLINElld:pubmed
pubmed-article:11160363pubmed:monthJanlld:pubmed
pubmed-article:11160363pubmed:issn0022-2275lld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:RosseneuMMlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:Vandekerckhov...lld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:CasterHHlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:PatelHHlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:VanlooBBlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:DuvergerNNlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:ShouldersCClld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:PeelmanFFlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:RoosbeekSSlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:BreyneJJlld:pubmed
pubmed-article:11160363pubmed:authorpubmed-author:De BeunIIlld:pubmed
pubmed-article:11160363pubmed:issnTypePrintlld:pubmed
pubmed-article:11160363pubmed:volume42lld:pubmed
pubmed-article:11160363pubmed:ownerNLMlld:pubmed
pubmed-article:11160363pubmed:authorsCompleteYlld:pubmed
pubmed-article:11160363pubmed:pagination31-40lld:pubmed
pubmed-article:11160363pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:meshHeadingpubmed-meshheading:11160363...lld:pubmed
pubmed-article:11160363pubmed:year2001lld:pubmed
pubmed-article:11160363pubmed:articleTitleThree arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.lld:pubmed
pubmed-article:11160363pubmed:affiliationLaboratory for Lipoprotein Chemistry, Department of Biochemistry, Ghent University, B-9000 Ghent, Belgium.lld:pubmed
pubmed-article:11160363pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160363lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160363lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160363lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160363lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160363lld:pubmed